A case of acute deterioration in asthma symptoms induced by isoniazid prophylaxis

Respiratory Medicine

Volumn 91, Issue 7, 1997, Pages 438-440

  Polosa, R ^a   Colombrita, R ^a   Prosperini, G ^a   Cacciola, R ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; ISONIAZID; PREDNISONE; SALBUTAMOL; TUBERCULOSTATIC AGENT;

ARTICLE; ASTHMA; CASE REPORT; CLINICAL FEATURE; DETERIORATION; HUMAN; INTRANASAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RESPIRATORY DISTRESS; SCHOOL CHILD;

EID: 0030790265     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90260-2     Document Type: Article

References (8)

1. American Thoracic Society. Treatment for tuberculosis and tuberculosis infection in adults and children: official statement. Am Rev Respir Dis 1986; 134: 355-363.
2. Joint Tuberculosis Committee of the British Thoracic Society. Control and prevention of tuberculosis in the United Kingdom: Code of Practice 1994. Thorax 1994; 49: 1193-1200.
3. Kopanoff DE, Snider DE, Caras G. Isoniazid-related hepatitis. Am Rev Respir Dis 1978; 117: 991-1001.
4. Sarma GP, Immanuel C, Kailasam S, Narayana ASL, Venkatesan P. Rifampicin-induced release of hydrazine from isoniazid. Am Rev Respir Dis 1986; 133: 1072-1078.
5. Torrent J, Izquierdo I, Cabezas R, Jane F. Theophylline-isoniazid interaction. DICP 1989; 23: 143-145.
6. Powell-Jackson PR, Gray BJ, Heaton RW, Costello JF, Williams R, English J. Adverse effect of rifampicin administration on steroid-dependent asthma. Am Rev Respir Dis 1983; 128: 307-310.
7. Shimoda T. Detection of IgE antibodies specific to isonicotinic acid hydrazide and its metabolite by ELISA and the mechanism of sensitization by inhalation or ingestion of this compound. Arerugi 1990; 39: 567-576.
8. Asai S, Shimoda P, Hara K, Fujiwara K.. Occupational asthma caused by isonicotinic acid hydrazide (INH) inhalation. J Allergy Clin Immunol 1987; 80: 578-582.